Figure 1 Figure 2 3 Mechanisms of action for GLP-1R agonists to control food intake GLP-1R agonists primarily act to reduce body weight by suppressing energy intake
User reports include reduced interest in gambling, compulsive shopping, and other impulsive behaviours
How the Program Works Medical consultation (telehealth or in-office) Comprehensive eligibility review and health assessment Prescription issued only after clinical approval Personalized dosing plan with gradual titration Ongoing follow-ups and progress monitoring Treatment is physician-guided to ensure safety, appropriate dosing, and long-term success
The SUSTAIN-6 trial published in 2016 showed that participants receiving weekly Ozempic (semaglutide) lost an average of 3-5 kg (8-11 lbs) after a two-year period (3)
Now, this is not something that I would say go DIY
Semaglutide, a GLP-1 receptor agonist, is studied extensively in metabolic and weight-related research